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Abstract
Cystic fibrosis (CF) respiratory epithelia exhibit abnormal
anion transport that may be linked to abnormal lung defense.
In these studies, we investigated whether primary cultures of
CF respiratory epithelial cells regulate abnormally the sulfate
content of high molecular weight glycoconjugates (HMG) par-
ticipating in airways' mucosal defense. HMG, including gly-
cosaminoglycans and mucin-type glycoproteins released spon-
taneously into medium and HMG released from cell surfaces
by trypsin, were metabolically labeled with 35So4= and 16-.I3I-
glucosamine (GlcN) or 35SO4- and [3H1serine. All three classes
ofHMG from CF cells exhibited 35S/3H labeling ratios 1.54-
fold greater than HMG from normal or disease control cells.
Differences for labeling ratios of HMG from CF cells were
shown to be the consequence of increased 35SO4= incorporation
rather than decreased peptide synthesis and release or HMG
glycosylation. The buoyant density of CF mucin-type HMG
also was increased, consistent with increased sulfation. These
observations suggest that oversulfation of a spectrum ofHMG
is a genetically determined characteristic ofCF epithelial cells
and may play an important pathophysiological role by altering
the properties of mucous secretions and/or the interactions
between selected bacteria and HMG at the airways' surface.
Introduction
Cystic fibrosis (CF)' is a genetic disease characterized by ab-
normal epithelial electrolyte transport. Failure to secrete Cl-
and excessive reabsorption ofNa' in the large airways' epithe-
lium ofCF patients (1-6) could lead to dehydration and accu-
mulation of secretions. However, these abnormalities alone
are unlikely to explain the progressive course of airway ob-
struction and persistent infection with specific microorgan-
isms such as Staphylococcus aureus and Pseudomonas aeru-
ginosa, because failure to clear secretions secondary to dys-
motile cilia (7) generally is associated with less severe airway
disease.
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1. Abbreviations used in this paper: CF, cystic fibrosis; DC, disease
control; GlcN, glucosamine; HMG, high molecular weight glycocon-
jugates; PAPS, 3'-phosphoadenosine 5'-phosphosulfate.
Previous studies showed that high molecular weight glyco-
conjugates (HMG) secreted by CF airways in situ (8) and in
organ culture (9, 10) are oversulfated. However, it has not been
clear whether this is an acquired abnormality ( I 1) or whether it
is related to the basic defect in CF. Recently, Yankaskas et al.
(12) demonstrated that CF nasal epithelial cells in primary
culture retain epithelial cell polarity and the electrolyte trans-
port properties that distinguish CF from normal or disease
control (DC) subjects. We have demonstrated that these cul-
tured cells produce and release sulfated HMG (13). We now
report that the HMG synthesized by cultured CF nasal epithe-
lial cells are more highly sulfated as compared with the HMG
produced by normal or DC cells.
Methods
Human tissues. Nasal polyps and turbinates surgically removed from
patients with allergic rhinitis (DC) or no known inflammatory process
in the upper airway (normal) were used for these studies. CF patients
had elevated levels of sweat chloride, typical pulmonary disease, and
pancreatic insufficiency. DC patients had seasonal rhinitis and eosino-
philia. Normal patients had obstructive sleep apnea or anatomic air-
way narrowing but no atopic symptoms (6). Details concerning tissue
donors are included in figure legends. Tissues were rinsed in normal
saline and transported to the laboratory in MEM at 4°C by ground
(local hospitals) or overnight air (distant hospitals) carrier.
Culture conditions. The epithelial cells were dissociated from
freshly excised nasal tissues by incubation in 0.1b% protease (Type XIV,
Sigma Chemical Co.) for 16 h and cultured on collagen matrices in
Ham's F-12 medium supplemented with hormones as described (12).
When cultured cells reached confluence, the media were changed to a
1 :1 mixture of hormone-supplemented F- 12 medium and DME con-
ditioned by 3T3 fibroblasts for 4 d. All confluent cultures showed
transepithelial electric potentials characteristic ofCF and non-CF cells
as previously noted ( 12).
Radiolabeling of newly synthesized HMG. HMG synthesized by
the cultured cells were labeled with radioisotope precursors, [6-3H]-
GlcN (25-40 Ci/mmol) (20 MCi/ml) and carrier-free Na235SO4 (100
jCi/ml), or [3H]serine (7-8 Ci/mmol) (40 ,Ci/ml) and Na35SO4 (100
uCi/ml), added to either the apical or basolateral medium. Except
where indicated, media were harvested daily and replaced with fresh
media. Because steady state secretion of radiolabeled HMG is reached
during the second day of culture (13), the apical media on days 2-4
were combined. HMG were isolated on Sepharose CL-6B (Pharmacia
Fine Chemicals, Piscataway, NJ) (14) and quantitated by liquid scin-
tillation counting. In all experiments, pairs ofCF and normal cells or
normal and DC cells were handled identically and studied in parallel.
Trypsin treatment ofcultured cells. Cultured cells were exposed to
porcine pancreatic trypsin (300 U/ml medium) added to the apical
compartment for 30 min. Soybean trypsin inhibitor was then intro-
duced at a final concentration of 200 ,ug/ml, before isolation and
quantitation of HMG as described above. Cultured cells exposed to
trypsin or medium alone were fixed in 2% formaldehyde 2% glutaral-
dehyde at 4°C overnight before Epon embedding for electron micros-
copy.
Other methods. Amino acid composition ofHMG was determined
by an HPLC procedure modified from that of Bidlinmeyer et al. (15).
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Modifications include addition of 200 mM boric acid to the acetate
buffer and the utilization ofan internal standard, 6-amino-n-hexanoic
acid, which is eluted 1-2 min before tyrosine. CsCl density gradient
centrifugation was performed at a starting density of 1.55 g/ml in a
rotor (type 65; Beckman Instruments, Fullerton, CA) at 10°C and
150,000 g for 35-45 h. Fractions were collected by a pump (Densi-
Flow Haake Buchler Instruments, Inc., Saddle Brook, NJ). The density
of each fraction was calculated from the refractive index and radioac-
tivity was measured by a liquid scintillation counter. Treatment with
bovine testicular hyaluronidase (400 U/ml, Sigma Chemical Co.) was
performed in 50 mM sodium acetate, pH 5.0, containing 2 mM PMSF
at 370 for4h(16).
Statistical Analyses. Data are expressed as means±SEM. Differ-
ences between means for each study group were analyzed by nonpaired
t test.
Results
Oversulfation ofHMG spontaneously released by CF cells.
Several lines of evidence suggest that radiolabeled HMG re-
leased by cultured CF cells are excessively sulfated. First, nor-
malizing 35SO4` incorporation to carbohydrate content as de-
termined by [3HJGlcN incorporation, we found that the mean
35S/3H(GlcN) ratio of total HMG released by cultured cells
into the apical bathing media was twofold higher for CF than
for normal or DC cells (Table I). 35S/3H(GlcN) ratios forHMG
released by normal and DC cells were not different. The ab-
normally higher ratio is due to increased 35S label associated
with HMG and not underglycosylation because the release rate
of I5S label associated with HMG (dpm/mm2 surface area)
during a 24-h period by CF cells (1.98±0.32 X 103) (n = 21
collagen matrices from 11 donors) was greater than that of
normal cells (1.16±0.21 X 103) (n = 20 collagen matrices from
10 donors) (P < 0.05) whereas the rate of release of 3H label
associated with HMG was not different for CF (8.94±1.69
X 103) (n = 21) and normal cells (9.82±1.82 X I03) (n = 20) (P
> 0.5). Second, when [3H]GlcN was replaced with [3H]Ser in
double-labeling experiments to normalize sulfate to peptide
content, the 3"S/3H(Ser) ratio for the HMG released by CF
cells was threefold higher than that of the HMG released by
normal and DC cells (Table II). Again, no difference was de-
tected for 35S/3H(Ser) ratios of HMG released from normal
and DC cells. We further verified that the rate of release of
HMG expressed as peptide content (,ug/d-cm2 surface area),
Table I. 35S/3H(GlcN) Ratios for HMG Released into Apical
Medium under Basal Culture Conditions*
Cells No. subjecst "5S/'H(GlcN) ratios P
Mean±SEM
Normal (N) 21 0.14±0.01 <0.001 (N vs. CF)
CF 12 0.28±0.03 <0.005 (CF vs. DC)
DC 13 0.15±0.05
* The diameter of collagen matrices was 3-5 mm. Labeling ratios did
not differ when precursors were added to the apical (0.6 ml) or baso-
lateral (1.0 ml) compartments. Greater than 88% of the radiolabeled
HMG released by cultured cells were recovered in the apical media.
* The gender and age of tissue donors are: normal, 12 males, 9 fe-
males, age range, 15-68, mean age, 33; CF, 4 males, 8 females, age
range, 6-20, mean age, 14; and DC, 4 males, 9 females, age range,
7-45, mean age, 28. 35S/3H(GlcN) ratios for normal, CF, or DC
groups did not change with sex or age.
Table II. 35S/3H(Ser) Ratios for HMG Released into Apical
Media under Basal Culture Conditions*
Cells No. subjectst "S/'H(Ser) ratios P
Mean±SEM
Normal 6 0.29±0.05 <0.001 (Nvs. CF)
CF 6 0.71±0.06 <0.00 (DC vs. CF)
DC 3 0.20±0.04 <.0 D s F
* The diameter of collagen matrices was 30 mm. Radiolabelled pre-
cursors were added to the basolateral medium (0.5 ml). Volume of
the apical compartment was 4 ml.
t The gender and age of nasal tissue donors were: normal, three
males, three females, age range, 5-40, mean age, 25; CF, three males,
three females, age range, 6-30, mean age, 18; and DC, one male, two
females, age range, 23-62, mean age, 39. No apparent sex- or age-re-
lated change in 35S/3H(ser) ratio was observed for any of these three
groups.
measured by amino acid analysis, was not different for cells
from these three sources: normal, 8.3±1.7 (n = 6); CF, 7.1+0.8
(n = 6); and DC, 7.9+0.3 (n = 3).
HMG released into media by cultured cells contain several
classes of glycoconjugates (13). Therefore, we examined
whether oversulfation ofHMG is a general phenomenon or is
limited to a specific class of HMG. When HMG isolated from
apical media were treated with bovine testicular hyaluroni-
dase, 49% of the 3H(GlcN)-label and 35% ofthe 35S label were
liberated from HMG, suggesting that glycosaminoglycans such
as chondroitin sulfates, dermatan sulfate, and hyaluronic acid
are released into the medium (16). The mean 35S/3H(GlcN)
ratio for hyaluronidase-susceptible HMG (glycosaminogly-
cans) released by CF cells (0.21±0.05) (n = 12) was 3.5 times
that for glycosaminoglycans from normal cells (0.06±0.01) (n
= 21) (P < 0.001). Similarly, the mean 35S/3H(GlcN) ratio of
hyaluronidase-resistant HMG from CF cells (0.26±0.02) (n
= 12) was 50% higher than that from normal cells (0. 17±0.01)
(n = 21) (P < 0.001). Approximately 40% of N-acetylgalactos-
amine in hyaluronidase-resistant HMG was converted to N-
acetylgalactosaminitol after alkaline borohydride treatment
(17), suggesting that these HMG contain mucin-type carbohy-
drate to peptide linkages. The mucin-type HMG from CF cells
were more heterogeneous than control HMG with respect to
density (Fig. 1, A and B). The peak buoyant density of hyal-
uronidase-resistant HMG released by normal cells was 1.52
and 1.53 g/ml for 3H label and 35S label, respectively (Fig. 1 A).
The peak buoyant density of hyaluronidase-resistant HMG
released by CF cells was 1.55 and 1.59 g/ml for 3H label and 35S
label, respectively (Fig. 1 B). Because sulfate is more dense
than either carbohydrates (18) or amino acids (19), these re-
sults are consistent with increased sulfation of CF mucin-
type HMG.
Increased sulfation ofcell surface HMG. Oversulfation was
not limited to CF HMG spontaneously released into the me-
dium. CF HMG released from the cell surface by trypsin had a
35S/3H(Ser) ratio 3-4-fold greater than that of normal or dis-
ease control HMG (Table III). Electron microscopy of the
apical membranes ofcultured cells treated with trypsin showed
substantial loss of glycocalyx over tips of microvilli (Fig. 2),
suggesting that the HMG released by trypsin are at least in part
associated with the apical cell surface.





























Figure 1. CsCl density gradient centrifugation profiles of hyaluroni-
dase-resistant HMG isolated from combined apical media of cul-
tured normal (A) and CF (B) cells. These glycoconjugates were cen-
trifuged at a starting density of 1.55 g/ml.
Discussion
Synthesis ofHMG peptides takes place at the rough endoplas-
mic reticulum using mRNAs as templates although glycosyl-
ation ofnewly synthesized peptides occurs in the Golgi appara-
tus in a step-wise manner catalyzed by a variety of glycosyl-
transferases. Oligosaccharides are then sulfated when their
assembly in the Golgi is near completion. Radiolabeled pre-
cursors, [3H]ser, [3H]GlcN, and 35SO4= used in this study serve
Table III. 35S/3H(Ser) RatiosforHMG Released by Trypsin*
Cells No. subjects 35S/3H(Ser) ratios P
Mean±SEM
Normal 6 0.28±0.09 <0.005 (N vs. CF)
CF 6 0.85±0.12
<. D s F
DC 3 0.20±0.04 <00(DvsCF
* After media were harvested on day 4, the cultured cells were ex-
posed to porcine pancreatic trypsin as described in the text. Tissue
donors and culture conditions are described in Table II.
as indices of peptide, carbohydrate, and sulfate contents, re-
spectively. The higher 35S/3H (GlcN or ser) ratios for CFHMG
as compared to non-CF HMG indicate that sulfation relative
to glycosylation or peptide synthesis is increased in CF cells.
Because rates of release of 3H(GlcN)-label associated with
HMG and HMG peptide measured chemically are not differ-
ent statistically between CF and non-CF cells while rate of
release of 3"S04-label associated with HMG is significantly
higher in CF as compared with non-CF cells, we conclude that
CF HMG are more heavily sulfated than non-CF HMG.
Higher buoyant density exhibited by CF mucin-type HMG is
consistent with this conclusion.
Previous studies demonstrating increased sulfation of
HMG secreted by CF airways in situ (8) or in organ culture (9,
10) have been interpreted by some to reflect an acquired ab-
normality, perhaps related to intensity of chronic airway in-
flammation (11). However, our studies show that increased
sulfation ofCF HMG persists during primary culture of nasal
epithelial cells, whereas HMG synthesized by DC nasal epithe-
lial cells in culture are not oversulfated as compared with nor-
mal controls. Therefore, oversulfation ofCF HMG can not be
attributed to the effects of chronic airways inflammation. We
propose that increased sulfation ofHMG is closely related to
the fundamental biochemical abnormality in CF epithelial
cells. Our observation that glycosaminoglycans as well as
mucin-type HMG released spontaneously from cultured cells
and cell surface HMG are oversulfated suggest that the CF
sulfation abnormality affects many or all sulfated respiratory
epithelial macromolecules.
Cellular events that potentially modulate the sulfation of
HMG are illustrated in Fig. 3 A. These include (a) transloca-
tion of sulfate ions across the plasma membrane by exchange
or conductive pathways identified in human skin fibroblasts
(20) and toad skin (21), respectively; (b) intracellular genera-
tion of sulfate from sulfur-containing amino acids (22); (c)
formation of 3'-phosphoadenosine 5'-phosphosulfate (PAPS)
from inorganic sulfate (22); and (d) transport ofPAPS across
the Golgi membrane to provide the sulfate donor for the syn-
thesis of sulfated macromolecules in the Golgi apparatus (23).
Current evidence suggests that sulfate metabolism exclusive of
transport is similar across species and tissue lines. If, as is
likely, the pool size or turn-over rate ofS04- is rate limiting for
HMG sulfation, the oversulfation of HMG by CF epithelial
cells does not necessarily add to the complexity of the funda-
mental cellular dysfunction. For example, as shown in Fig. 3
B, several previously described abnormalities ofCF epithelial
cell ion transport or metabolic pathways could perturb the
kinetics of the S04= pool: (a) abnormal regulation (1-5) of a
putative cellular S04= transporter (20); (b) increased ATP sup-
plies (24); and/or (c) alteration of a functional anion conduc-
tance that would limit the efflux of intracellular S04- (21).
Current evidence suggests that CF epithelial cell dysfunc-
tion, particularly abnormal Cl- (and perhaps Na+) transloca-
tion across the apical membrane, can be traced to a malfunc-
tioning regulatory step downstream from the regulatory ki-
nases (1-6). A projected consequence of this ion transport
dysfunction is a failure to provide water in adequate amounts
for hydration of airways surface liquids, which may alter the
viscoelastic properties of mucous gels (25, 26). Increased sul-
fation ofHMG also may contribute to altered physical proper-
ties of mucus (27). However, as indicated above, reduced
mucus clearance alone can not adequately explain coloniza-
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tion ofCF airways by selective microbial pathogens. For exam-
ple, patients with other genetic diseases that lack mucociliary
clearance generally are not infected with these microorganisms
and do not usually succumb to lung disease in the first two to
three decades of life (7). We speculate that oversulfated epithe-
lial HMG provide a clue to the selection of P. aeruginosa and
S. aureus in CF airways by (a) providing a favored site for
binding of these bacteria (28, 29) at epithelial cell surfaces
and/or (b) adversely influencing the interaction between HMG
components of airways secretions and specific microorgan-
isms (8).
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